Anticoagulation by Ancrod for HaemodialysisBr Med J 1970; 4 doi: https://doi.org/10.1136/bmj.4.5735.591 (Published 05 December 1970) Cite this as: Br Med J 1970;4:591
- G. H. Hall,
- Hazel M. Holman,
- A. D. B. Webster
The defibrinating agent ancrod (Arvin) was used instead of heparin for intermittent haemodialysis. It was an effective, and apparently safe, anticoagulant and reduced the deposition of fibrin and leucocytes on the Cellophane membrane. Administration was more complicated and urea dialysance was less with ancrod than with heparin.